Graham Doyle
Stock Analyst at UBS
(0.89)
# 4,027
Out of 4,835 analysts
402
Total ratings
48.6%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Graham Doyle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €56.00 | €45.29 | +23.66% | 49 | Sep 8, 2026 | |
| SWX: STMN Straumann Holding AG | Upgraded: Buy | CHF 90.00 → CHF 115.00 | CHF 94.06 | +22.26% | 17 | Sep 1, 2026 | |
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,300p → 1,120p | 1,016p | +10.24% | 21 | Aug 25, 2026 | |
| ETR: OBCK Ottobock SE & Co. KGaA | Reiterated: Buy | €74.00 → €78.00 | €55.60 | +40.29% | 6 | Aug 24, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 86.00 → CHF 83.00 | CHF 53.90 | +53.99% | 30 | Aug 14, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Downgraded: Sell | €25.00 → €22.60 | €30.14 | -25.02% | 54 | Aug 11, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 375p | 218p | +72.33% | 22 | Aug 6, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €37.00 → €36.00 | €38.59 | -6.71% | 55 | Aug 4, 2026 | |
| ETR: SHL Siemens Healthineers AG | Reiterated: Hold | €38.00 | €38.31 | -0.81% | 49 | Aug 3, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Downgraded: Hold | €32.50 → €24.00 | €21.25 | +12.94% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $67 → $73 | $63.76 | +14.49% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 151.00 → CHF 148.00 | CHF 114.20 | +29.60% | 6 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | kr 39.00 | kr 49.12 | -20.60% | 1 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 215.00 | CHF 228.40 | -5.87% | 15 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $112.28 | n/a | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11,780.00 | n/a | 5 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,779.00 | n/a | 3 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €90.00 | €48.40 | n/a | 1 | Jan 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 275.00 | CHF 345.00 | n/a | 1 | Jun 20, 2019 |
Fresenius SE & Co. KGaA
Sep 8, 2026
Reiterated: Buy
Price Target: €56.00
Current: €45.29
Upside: +23.66%
Straumann Holding AG
Sep 1, 2026
Upgraded: Buy
Price Target: CHF 90.00 → CHF 115.00
Current: CHF 94.06
Upside: +22.26%
Smith & Nephew plc
Aug 25, 2026
Reiterated: Hold
Price Target: 1,300p → 1,120p
Current: 1,016p
Upside: +10.24%
Ottobock SE & Co. KGaA
Aug 24, 2026
Reiterated: Buy
Price Target: €74.00 → €78.00
Current: €55.60
Upside: +40.29%
Alcon Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: CHF 86.00 → CHF 83.00
Current: CHF 53.90
Upside: +53.99%
Carl Zeiss Meditec AG
Aug 11, 2026
Downgraded: Sell
Price Target: €25.00 → €22.60
Current: €30.14
Upside: -25.02%
Convatec Group PLC
Aug 6, 2026
Reiterated: Buy
Price Target: 375p
Current: 218p
Upside: +72.33%
Fresenius Medical Care AG
Aug 4, 2026
Reiterated: Sell
Price Target: €37.00 → €36.00
Current: €38.59
Upside: -6.71%
Siemens Healthineers AG
Aug 3, 2026
Reiterated: Hold
Price Target: €38.00
Current: €38.31
Upside: -0.81%
Koninklijke Philips N.V.
Aug 3, 2026
Downgraded: Hold
Price Target: €32.50 → €24.00
Current: €21.25
Upside: +12.94%
Jul 31, 2026
Rated: Hold
Price Target: $67 → $73
Current: $63.76
Upside: +14.49%
Jul 21, 2026
Reiterated: Hold
Price Target: CHF 151.00 → CHF 148.00
Current: CHF 114.20
Upside: +29.60%
May 21, 2026
Downgraded: Sell
Price Target: kr 39.00
Current: kr 49.12
Upside: -20.60%
Mar 24, 2026
Reiterated: Hold
Price Target: CHF 215.00
Current: CHF 228.40
Upside: -5.87%
Jan 25, 2022
Downgraded: Hold
Price Target: n/a
Current: $112.28
Upside: n/a
May 29, 2020
Reiterated: Buy
Price Target: n/a
Current: $11,780.00
Upside: n/a
May 28, 2020
Reiterated: Hold
Price Target: n/a
Current: $1,779.00
Upside: n/a
Jan 22, 2020
Reiterated: Buy
Price Target: €90.00
Current: €48.40
Upside: n/a
Jun 20, 2019
Downgraded: Hold
Price Target: CHF 275.00
Current: CHF 345.00
Upside: n/a